Jury Awards Boehringer $7M In Patent Suit Vs. Schering-Plough
The jury in the U.S. District Court for the District of New Jersey awarded the amount based on a prior decision finding infringement of a Boehringer-Ingelheim patent in 2000, according to Schering-Plough.
The jury found that the Schering-Plough’s PRIME PAC PRRS (Porcine Respiratory and Reproductive Syndrome) vaccine infringed a patent owned by Boehringer-Ingelheim Vetmedica, Inc.
Boehringer-Ingelheim’s patent covers a vaccine for PRRS, a major killer of...
To view the full article, register now.